学术兼职:
中国药理学会临床药理专业委员会委员
中国医药教育协会循证药学研究与评价委员会委员
中国医学装备协会医疗器械创新与应用分会委员
PSM眼科药学专业委员会委员
浙江省药学会转化药学专业委员会委员
浙江省数理医学会智慧药学与合理用药专业委员会委员
浙江省药学会询证药学专业委员会委员
浙江省药学会基层医院合理用药专业委员会委员
温州市药学会临床药学专业委员会委员
温州市药学会医院药学专业委员会委员
温州市医学会医院药学专业委员会委员
温州市VTE防治联盟委员会药学分会委员
温州市老年健康工作专家库成员
浙江省药品化妆品审评中心GCP检查专家
工作成果:
牵头建设GMP标准无菌制剂室,获批2个新制剂的院内制剂批件,在研制剂项目3个。
以第一发明人获授权发明专利5项,实用新型专利9项,部分专利已完成知识产权成果转化。
参与临床试验项目五十余项,参与编写药典配套丛书《临床用药须知》,《眼科医疗质量管理与评价》,《玻璃体腔注射(IVI)药物的药学服务专家共识》等。
以第一作者或通讯作者发表国内外论文二十余篇,主持或参与多项省市级课题。
Academic Appointments:
Member, Professional Committee of Clinical Pharmacology, Chinese Pharmacological Society
Member, Committee on Evidence-based Pharmacy Research and Evaluation, China Pharmaceutical Education Association
Member, Branch of Medical Device Innovation and Application, China Medical Equipment Association
Member, Professional Committee of Ophthalmic Pharmacy, PSM (Pharmaceutical Safety Monitoring)
Member, Professional Committee of Translational Pharmacy, Zhejiang Pharmaceutical Association
Member, Professional Committee of Smart Pharmacy and Rational Drug Use, Zhejiang Mathematical Medicine Association
Member, Professional Committee of Evidence-based Pharmacy, Zhejiang Pharmaceutical Association
Member, Professional Committee of Rational Drug Use in Primary Hospitals, Zhejiang Pharmaceutical Association
Member, Professional Committee of Clinical Pharmacy, Wenzhou Pharmaceutical Association
Member, Professional Committee of Hospital Pharmacy, Wenzhou Pharmaceutical Association
Member, Professional Committee of Hospital Pharmacy, Wenzhou Medical Association
Member, Pharmacy Branch of Wenzhou VTE Prevention and Control Alliance Committee
Member, Expert Database for Elderly Health Work, Wenzhou
Professional Achievements:
Led the research and development of 2 new hospital preparations, obtaining approval documents, and 3 preparation projects are under development.
Applied for 17 patents as the first inventor, with 3 authorized invention patents and 6 utility model patents; some patents have completed intellectual property achievement transformation.
Participated in more than 30 clinical trial projects, and contributed to compiling supporting books of the Pharmacopoeia, including Clinical Medication Guidelines, Ophthalmic Medical Quality Management and Evaluation, and Expert Consensus on Pharmaceutical Care for Intravitreal Injection (IVI) Drugs.
8
0
0
| 日期 | 时间 | 会场 | Session | 角色 | 讲题 |
|---|---|---|---|---|---|
| 2026-05-29 | 16:00-17:55 | 分会场14(二层,N220会议室) |
中国眼科器械创新&生态建设与全球化发展论坛(上) |
讨论 | |
| 2026-05-29 | 16:55-17:10 | 分会场14(二层,N220会议室) |
中国眼科器械创新&生态建设与全球化发展论坛(上) |
讲者 | 成果发布: 临床试验立项和伦理审查同质化进展 |
| 2026-05-30 | 16:45-17:05 | 分会场9(二层,N215会议室) |
2026年质启新阶・研创致远-临床试验高质量发展培训会暨眼科药物/医疗器械临床试验联盟工作会议 |
讲者 | ICH GCP E6(R3)核心要点与落地实施的思考 |
| 2026-05-30 | 17:20-17:25 | 分会场9(二层,N215会议室) |
2026年质启新阶・研创致远-临床试验高质量发展培训会暨眼科药物/医疗器械临床试验联盟工作会议 |
讲者 | 开场致辞/联盟介绍 |
| 2026-05-30 | 17:30-18:30 | 分会场9(二层,N215会议室) |
2026年质启新阶・研创致远-临床试验高质量发展培训会暨眼科药物/医疗器械临床试验联盟工作会议 |
讨论 | 讨论议题1、下一年度临床试验行业统一共识体系建设规划 2、聚力临床试验质量效能双提升,优化全流程管控与实施路径 3、多中心临床研究的伦理协作审查协议和操作规程 4、多中心临床研究的伦理审查时间线协调与提速策略 |